Melanoma tumors, along with hepatocellular cancer (HCC) and prostate cancer, frequently show deficiency of the enzyme argininosuccinate synthetase (ASS) [315], cannot synthesize arginine from citrulline, and depend on exogenous arginine for survival. Here, ASS1 is linked to prostate carcinoma.